New developments in the understanding of the actions of the digitalis glycosides.
D000818:Animals; D001775:Blood Circulation / Q000187:drug effects; D002118:Calcium / Q000378:metabolism; D004071:Digitalis Glycosides / Q000008:administration & dosage / Q000009:adverse effects / Q000378:metabolism / Q000494:pharmacology* / Q000627:therapeutic use / Q000633:toxicity; D004357:Drug Synergism; D006321:Heart / Q000187:drug effects*; D006331:Heart Diseases / Q000188:drug therapy; D006333:Heart Failure / Q000188:drug therapy*; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D009206:Myocardium / Q000032:analysis / Q000378:metabolism*; D009638:Norepinephrine / Q000008:administration & dosage; D011188:Potassium / Q000008:administration & dosage / Q000378:metabolism; D012110:Reserpine / Q000008:administration & dosage; D013610:Tachycardia / Q000188:drug therapy; D013963:Thyroid Hormones / Q000008:administration & dosage
D004071:Digitalis Glycosides; D013963:Thyroid Hormones; D012110:Reserpine; D011188:Potassium; D002118:Calcium; D009638:Norepinephrine